Precigen to Participate in a Fireside Chat with H.C. Wainwright on March 31

Core Insights - Precigen, Inc. will participate in a virtual fireside chat with H.C. Wainwright on March 31, 2026, featuring President and CEO Helen Sabzevari, PhD, and Chief Commercial Officer Phil Tennant [1][2]. Company Overview - Precigen, Inc. is a commercial-stage biopharmaceutical company focused on innovative precision medicines aimed at addressing difficult-to-treat diseases with high unmet patient needs [3]. - The company is committed to advancing scientific breakthroughs from proof-of-concept through commercialization, developing a robust pipeline in immuno-oncology, autoimmune disorders, and infectious diseases [3].